ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,938, issued on May 13, was assigned to SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (Seoul, South Korea) and RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY (Gyeonggi-do, South Korea).
"Composition for treating castration-resistant prostate cancer, comprising quassinoids" was invented by Jeong Hoon Kim (Seoul, South Korea), Byong Chang Jeong (Seoul, South Korea) and Sue Jin Moon (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to: a composition for treating castration-resistant prostate cancer, comprising quassinoids; and a method for treating castration-resistant prostate cancer by using same."
The ...